Becton, Dickinson and Company (BDX)
Looking for a Growth Stock? 3 Reasons Why Becton Dickinson (BDX) is a Solid Choice
Becton Dickinson (BDX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
BDX or MMSI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
Becton, Dickinson and Company (BDX) Q4 2024 Earnings Call Transcript
Becton, Dickinson and Company (NYSE:BDX ) Q4 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer & Head of Investor Relations Tom Polen - Chairman, Chief Executive Officer & President Chris DelOrefice - Executive Vice President & Chief Financial Officer Mike Garrison - President of Medical Segment Conference Call Participants Vijay Kumar - Evercore ISI Larry Biegelsen - Wells Fargo Travis Steed - Bank of America Robbie Marcus - JPMorgan Patrick Wood - Morgan Stanley David Roman - Goldman Sachs Matt Miksic - Barclays Matt Taylor - Jefferies Rick Wise - Stifel Operator Hello and welcome to BD's Fourth Quarter and Full Year Fiscal 2024 Earnings Call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com, or by phone at 800-839-1337 for domestic calls and area code +1-402-220-0489 for international calls.
BDX Stock Gains Following Q4 Earnings Beat and Higher Margins
BD's overall topline in the fourth quarter of fiscal 2024 benefits from revenue growth in all segments.
Becton Dickinson (BDX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Becton Dickinson (BDX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Becton Dickinson (BDX) Q4 Earnings and Revenues Surpass Estimates
Becton Dickinson (BDX) came out with quarterly earnings of $3.81 per share, beating the Zacks Consensus Estimate of $3.77 per share. This compares to earnings of $3.42 per share a year ago.
Becton Dickinson beats quarterly estimates on strength in drug-delivery devices
Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices.
Can Sustained Product Demand Drive BDX Stock Before Q4 Earnings?
Continued solid uptake of BD's products is expected to have driven fiscal fourth-quarter revenues.
Insights Into Becton Dickinson (BDX) Q4: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Becton Dickinson (BDX) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Becton, Dickinson And HP Among 13 Companies To Announce Annual Dividend Increases In First Half Of November
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. I expect 13 companies to announce their annual increases in the first half of November, including double-digit increases from Automatic Data Processing, Roper Technologies, and Snap-on. Investors saw good 10%+ increases from insurer Brown & Brown, payment processor Visa, and specialty chemical company RPM in October.
BDX Stock Declines Despite Launching BD IO Vascular Access System
BD announces the BD Intraosseous Vascular Access System to enable quick vascular access for critical care situations.
Becton Dickinson (BDX) Earnings Expected to Grow: Should You Buy?
Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
